— DexCom, Inc. (NASDAQ: DXCM) reported its fourth-quarter 2019 adjusted earnings of $1.15 per share versus $0.74 per share expected.
— Total revenue grew by 37% to $462.8 million versus $442.38 million expected. This is driven by volume growth, strong new patient additions as well as an increase in awareness of real-time CGM.
— The US revenue increased by 34% year-over-year and the international revenue jumped by 52%.
— Revenue from the sensor increased by 42% for the fourth quarter. Transmitter revenue jumped by 46% while receiver revenue plunged by 35%.
— Looking ahead into the full year 2020, the company reaffirmed revenue outlook in the range of $1.725-1.775 billion. This is in line with the consensus view of $1.77 billion.
— The revenue outlook is driven by strong growth in sensor volumes, continued international expansion, shifting channel mix and overall market dynamics.
— The gross margin is still expected to be about 64% and the adjusted operating margin is predicted to be about 13%. The adjusted EBITDA margin outlook is about 23%.
Most Popular
GIS Earnings: All you need to know about General Mills’ Q1 2025 earnings results
General Mills, Inc. (NYSE: GIS) reported its first quarter 2025 earnings results today. Net sales decreased 1% year-over-year to $4.8 billion. Organic sales were down 1%. Net earnings attributable to
Guardian Pharmacy seeks to raise up to $108 mil in US IPO
Joining the wave of healthcare IPOs this year, amid Fed rate cut expectations, Guardian Pharmacy Services, Inc. is preparing to go public. In a statement filed with the Securities and
Earnings Preview: Will Micron (MU) maintain recovery momentum in Q4?
After recovering from a rough patch, Micron Technology Inc. (NASDAQ: MU) is preparing to report fourth-quarter results next week, even as the market keeps a close watch on the event
